Takeover targets could increase under Trump and lead to massive gains.
|
H&E Equipment Services, Inc. – SYM: HEES Recent Price: $89.39 Takeover Action: United Rentals intends to commence a tender offer by January 28, 2025, to acquire all of the outstanding shares of H&E common stock for $92 per share in cash. Description: H&E Equipment Services, Inc. operates as an integrated equipment services company in the United States. The company operates in five segments: Equipment Rentals, Sales of Rental Equipment, Sales of New Equipment, Parts Sales, and Repair and Maintenance Services. The Equipment Rentals segment provides construction and industrial equipment for rent on a daily, weekly, and monthly basis. The Sales of Rental Equipment segment sells used equipment from its rental fleet. The Sales of New Equipment segment sells new construction equipment through a professional sales force. The Parts Sales segment provides parts to its rental fleet and sells parts for the equipment, as well as maintains parts inventory. The Repair and Maintenance Services segment provides maintenance and repair services to its rental fleet and customers' equipment at its facilities, as well as at customers' locations. It also provides ancillary equipment support activities, including transportation, hauling, parts shipping, and loss damage waivers. The company's rental fleet consists of aerial work platforms, cranes, earthmoving and material handling equipment, and other general and specialty lines. It serves industrial and commercial companies, construction contractors, manufacturers, public utilities, municipalities, maintenance contractors, and various other industrial account customers. H&E Equipment Services, Inc. was founded in 1961 and is headquartered in Baton Rouge, Louisiana. |
Apartment Investment and Management Company – SYM: AIV Recent Price: $9.16 Takeover Action: Land & Buildings Investment Management asked Apartment Investment and Management to immediately pursue the company’s strategic review through a sale of the whole company. Land & Buildings estimates the net asset value of the remaining portfolio to be $11.50/share. Description: Aimco is a diversified real estate company primarily focused on value add and opportunistic investments, targeting the U.S. multifamily sector. Aimco's mission is to make real estate investments where outcomes are enhanced through our human capital so that substantial value is created for investors, teammates, and the communities in which we operate. Aimco is traded on the New York Stock Exchange as AIV. |
Intra-Cellular Therapies, Inc. – SYM: ITCI Recent Price: $126.75 Takeover Action: Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies for a payment of $132.00 per share in cash. Description: Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. |
|
|
Our mailing address is: DC2 Publishing LLC 4260 NW 1st Avenue Suite # 55 Boca Raton, FL 33431 - 4264 Daily Insider Trades Copyright © 2024 DC2 Publishing LLC, All rights reserved. You're receiving this email as part of your subscription to Daily Insider Trades. For more information about our privacy practices, please review our Privacy Policy or our Terms of Use. |
Click here to unsubscribe | |
|
|